Description
TOPASIGN 50 TABLET is a prescription medication comprising Topiramate 50 mg, an antiepileptic drug (AED) with proven efficacy in managing seizures and preventing migraines. Topiramate belongs to the sulfamate-substituted monosaccharide class and works through multiple mechanisms, including enhancing GABA activity, inhibiting glutamate receptors, and blocking voltage-gated sodium and calcium channels.
This multi-action mechanism makes TOPASIGN suitable for a wide range of seizure disorders, including partial-onset seizures, generalized tonic-clonic seizures, and seizures associated with Lennox-Gastaut syndrome. It is also clinically approved for migraine prophylaxis in adults and adolescents.
Manufactured and supplied by Bluepill Express, a globally recognized third-party pharmaceutical exporter, TOPASIGN 50 TABLET is produced in WHO-GMP certified facilities and is available for international markets, including bulk exports and private labelling.
-
Contains Topiramate 50 mg – broad-spectrum antiepileptic
-
Effective in controlling a wide range of seizure types
-
Used in migraine prevention therapy
-
Manufactured under international quality certifications
-
Globally exported by Bluepill Express
-
Partial-onset seizures in adults and children
-
Primary generalized tonic-clonic seizures
-
Lennox-Gastaut syndrome (as adjunctive therapy)
-
Prophylaxis of migraine headaches
-
Enhances the activity of GABA (gamma-aminobutyric acid) – an inhibitory neurotransmitter
-
Inhibits AMPA/kainate subtype of glutamate receptors (excitatory neurotransmission)
-
Blocks voltage-gated sodium channels, stabilizing neuronal membranes
-
Inhibits certain calcium channels, reducing neurotransmitter release
-
Dosage depends on the indication and patient profile
-
Typically initiated at low doses and titrated gradually to minimize side effects
-
Should be taken orally with or without food
-
Always follow the dosage as prescribed by a physician
-
Not recommended during pregnancy unless clearly needed (risk of birth defects)
-
Use caution in patients with renal or hepatic impairment
-
May cause drowsiness, dizziness, or cognitive disturbances
-
Adequate hydration is advised to prevent kidney stones
-
Sudden withdrawal may lead to seizure recurrence
-
Fatigue, dizziness, drowsiness
-
Loss of appetite, weight loss
-
Cognitive issues (memory, attention)
-
Nausea, tingling in limbs
-
Mood changes or depression (rare)
-
Store at room temperature (below 30°C)
-
Protect from moisture and direct sunlight
-
Keep out of reach of children
-
Produced in WHO-GMP, ISO, and other certified facilities
-
Complies with global export documentation and regulations
-
Available for bulk orders, custom packaging, and third-party branding
-
Trusted by healthcare providers and pharmaceutical distributors worldwide
-
Backed by Bluepill Express, a leader in global medicine exports